A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease
- PMID: 17900320
- DOI: 10.1111/j.1572-0241.2007.01548.x
A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease
Abstract
Objective: This study used meta-analytical techniques to compare the incidence of recurrence and the indication for reoperation in patients with Crohn's disease (CD) who underwent their first operation, due to perforating disease versus patients who underwent their first operation due to nonperforating disease.
Methods: Comparative studies published between 1988 and 2005 of perforating versus nonperforating CD were included. Using a random effects model, end points evaluated were recurrence of CD given as reoperation, and the indication for reoperation, i.e., perforating or nonperforating. Heterogeneity (HG) was assessed and a sensitivity analysis was performed to account for bias in patient selection.
Results: Thirteen studies (12 nonrandomized retrospective, 1 nonrandomized prospective) reported on 3,044 patients, of which 1,337 (43.9%) had perforating indications (P group) and 1,707 (56.1%) had nonperforating indications (NP group) for surgery. The recurrence was found to be significantly higher in the P group compared to the NP group (HR 1.50, P= 0.002), with significant HG among studies (P < 0.001). The recurrence remained significantly higher in the P group compared with the NP group during sensitivity analysis of high-quality studies (HR 1.47, P= 0.005) and more recent studies (HR 1.51, P= 0.05), but still demonstrating significant HG (P= 0.08 and P < 0.001, respectively). At reoperation, concordance was found in the disease type of those patients re-presenting with perforating disease (OR 5.93, P < 0.001, without significant HG among studies P= 0.15) and those with nonperforating disease (OR 5.73, P < 0.001, with significant HG among studies P < 0.001). Concordance in disease type remained when considering only high-quality studies (P: OR 7.48, P < 0.001; NP: OR 7.48, P < 0.001) and more recent studies (P: OR 5.95, P < 0.001; NP: OR 5.95, P < 0.001), both not associated with HG among studies (P= 0.47 and P= 0.60, respectively).
Conclusions: The indication for reoperation in CD tends to be the same as the primary operation, i.e., perforating disease tends to re-present as perforating disease, and nonperforating as nonperforating. Also, perforating CD appears to be associated with a higher recurrence rate compared with nonperforating CD. However, because of significant HG among studies, further studies should be undertaken to confirm this finding.
Similar articles
-
Meta-analysis of the role of granulomas in the recurrence of Crohn disease.Dis Colon Rectum. 2010 Feb;53(2):177-85. doi: 10.1007/DCR.0b013e3181b7bfb0. Dis Colon Rectum. 2010. PMID: 20087093 Review.
-
[Comparison of long-term course of perforating and non-perforating Crohn disease].Gastroenterol Clin Biol. 1998 Jun-Jul;22(6-7):601-6. Gastroenterol Clin Biol. 1998. PMID: 9762331 French.
-
A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease.Dis Colon Rectum. 2007 Oct;50(10):1674-87. doi: 10.1007/s10350-007-9011-8. Dis Colon Rectum. 2007. PMID: 17682822
-
Efficacy of nutritional therapy for perforating and non-perforating Crohn's disease.Hepatogastroenterology. 2004 Jul-Aug;51(58):1050-2. Hepatogastroenterology. 2004. PMID: 15239244
-
[The minimal bowel resection in Crohn's disease: analysis of prognostic factors on the surgical recurrence].Ann Ital Chir. 2003 Nov-Dec;74(6):627-33. Ann Ital Chir. 2003. PMID: 15206803 Review. Italian.
Cited by
-
Medical therapies for postoperative Crohn's disease.Therap Adv Gastroenterol. 2021 Feb 15;14:1756284821993581. doi: 10.1177/1756284821993581. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 33643440 Free PMC article. Review.
-
Frequency and risk factors of postoperative recurrence of Crohn's disease after intestinal resection in the Chinese population.J Gastrointest Surg. 2012 Aug;16(8):1539-47. doi: 10.1007/s11605-012-1902-x. Epub 2012 May 4. J Gastrointest Surg. 2012. PMID: 22555673
-
Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea.Ann Coloproctol. 2015 Aug;31(4):144-52. doi: 10.3393/ac.2015.31.4.144. Epub 2015 Aug 31. Ann Coloproctol. 2015. PMID: 26361616 Free PMC article.
-
Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.Dig Dis Sci. 2017 Jan;62(1):188-196. doi: 10.1007/s10620-016-4351-7. Epub 2016 Oct 24. Dig Dis Sci. 2017. PMID: 27778204
-
Gut Microbiota Profiles and Microbial-Based Therapies in Post-operative Crohn's Disease: A Systematic Review.Front Med (Lausanne). 2021 Jan 28;7:615858. doi: 10.3389/fmed.2020.615858. eCollection 2020. Front Med (Lausanne). 2021. PMID: 33585513 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous